FDA: Mifepristone review won’t be done until March
Healthcare News – Read More The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in…
Healthcare News – Read More The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in…